Heron Therapeutics is trading at $0.34, up 10.05% on October 1, 2026, with no clear company-specific catalyst identified.
- Its investor-relations release archive lists no October 1 announcement; the latest listed release is dated July 27.
- Major indices were only modestly higher, which does not clearly explain the gain.
- Available evidence points to an unexplained price move, not a confirmed company or broad-market driver.